Hilltop vs Origin Bancorp
HTH and OBK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HTH and OBK compare
Hilltop is the larger company, worth 1.2 times as much as Origin Bancorp ($2.0B against $1.7B).
On earnings, Origin Bancorp is cheaper: it trades at 13.0× trailing earnings, against 15.0× for Hilltop.
Origin Bancorp grew revenue faster over the last twelve months (17.2% versus 0.21% for Hilltop).
Origin Bancorp keeps more of each dollar of sales as profit, with a net margin of 30.1% compared with 11.2% at Hilltop.
Both pay dividends: Hilltop yields 1.7% and Origin Bancorp 1.5%.
Origin Bancorp scores higher on the StockData Score (14 against 12 for Hilltop), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HTH | OBK |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $1.7B |
| Share price | $36.08 | $54.00 |
| Change, 1 year | 7.0% | 51.8% |
| Change, 5 years | −0.93% | 18.5% |
| Beta (5Y) | 0.69 | 0.73 |
| Employees | 3,500 | 988 |
| StockData Score | ||
| Total score | 12 | 14 (better) |
| Valuation score | 4 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 15.0× | 13.0× (better) |
| P/S | 1.6× (better) | 3.9× |
| P/B | 1.0× (better) | 1.3× |
| P/FCF | 18.6× | 11.2× (better) |
| PEG | 0.83 | – |
| FCF yield | 5.4% | 8.9% (better) |
| Fair value | $37.28 | $48.13 |
| Margin of safety | 3.2% (better) | −12.2% |
| Growth | ||
| Revenue growth (TTM) | 0.21% | 17.2% (better) |
| Revenue growth, 5Y average | −9.5% | 8.8% (better) |
| Net income growth (TTM) | −11.7% | 115% (better) |
| EPS growth (TTM) | −4.4% | 117% (better) |
| EPS growth, 5Y average | −12.0% | 9.1% (better) |
| Profitability | ||
| Net margin | 11.2% | 30.1% (better) |
| FCF margin | 8.8% | 34.8% (better) |
| Return on equity | 6.6% | 10.4% (better) |
| Financial health | ||
| Debt / equity | 0.39 | – |
| Altman Z-score | 0.27 (better) | 0.25 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.7% (better) | 1.5% |
| Payout ratio | 33.4% | 19.4% |
| Years of dividend growth | 9 (better) | 0 |
| Dividend growth, 5Y average | 14.9% (better) | 9.7% |
| Buyback yield | 8.6% (better) | 2.0% |
| Shareholder yield | 10.3% (better) | 3.5% |
| Ownership | ||
| Held by institutions | 56.3% | 67.8% |
| Held by insiders | 61.0% | 5.8% |
| Insider net buying, 12 months | −$15.3M | $220K (better) |
| Short interest, % of float | 9.6% | – |
Go deeper
- HTH stock overview
- HTH income statement
- HTH valuation and score
- OBK stock overview
- OBK income statement
- OBK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.